Clinical Trial Update: Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study [Phase 2]

View source ↗

Summary

Aeris Therapeutics' Phase 2 Biologic Lung Volume Reduction study in homogeneous emphysema has completed, with results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emphysema

Snippet

Sponsor: Aeris Therapeutics | Conditions: Homogeneous Emphysema | Phase 2 | Status: COMPLETED